150 related articles for article (PubMed ID: 10773760)
1. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.
Shikano M; Sobajima H; Yoshikawa H; Toba T; Kushimoto H; Katsumata H; Tomita M; Kawashima S
Nephron; 2000 May; 85(1):81-5. PubMed ID: 10773760
[TBL] [Abstract][Full Text] [Related]
2. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
Nakamura A; Shikata K; Hiramatsu M; Nakatou T; Kitamura T; Wada J; Itoshima T; Makino H
Diabetes Care; 2005 Dec; 28(12):2890-5. PubMed ID: 16306550
[TBL] [Abstract][Full Text] [Related]
5. The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy.
Liu F; Guo J; Zhang Q; Liu D; Wen L; Yang Y; Yang L; Liu Z
PLoS One; 2015; 10(10):e0141471. PubMed ID: 26517838
[TBL] [Abstract][Full Text] [Related]
6. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
[TBL] [Abstract][Full Text] [Related]
7. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
8. [Increased urinary excretion of transforming growth factor beta and interleukin-6 in patients with diabetic nephropathy].
Królak R; Paczek L; Rogala H; Bartłomiejczyk I; Gradowska L; Korczak D; Gaciong Z
Pol Arch Med Wewn; 1996 Dec; 96(6):545-51. PubMed ID: 9139274
[TBL] [Abstract][Full Text] [Related]
9. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
Banu N; Hara H; Egusa G; Yamakido M
Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.
Navarro JF; Mora C; Maca M; Garca J
Am J Kidney Dis; 2003 Jul; 42(1):53-61. PubMed ID: 12830456
[TBL] [Abstract][Full Text] [Related]
11. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
12. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
13. The role of determining the levels of serum collagen type IV in diagnosing early diabetic nephropathy.
Xu X; Wu Z; Zhou Q; Zhang Y; Wu D
Ren Fail; 2002 Nov; 24(6):747-53. PubMed ID: 12472197
[TBL] [Abstract][Full Text] [Related]
14. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes.
Li Q; Gong W; Yang Z; Lu B; Yang Y; Zhao W; Hu R
Diabetes Res Clin Pract; 2013 Jun; 100(3):385-90. PubMed ID: 23602322
[TBL] [Abstract][Full Text] [Related]
15. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
16. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T
Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747
[TBL] [Abstract][Full Text] [Related]
17. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.
Hayashi Y; Makino H; Ota Z
Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709
[TBL] [Abstract][Full Text] [Related]
18. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
19. Serum and urinary cytokine homeostasis and renal tubular function in children with type 1 diabetes mellitus.
Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipska BS; Wiśniewski P; Myśliwski A
J Pediatr Endocrinol Metab; 2006 Dec; 19(12):1421-7. PubMed ID: 17252695
[TBL] [Abstract][Full Text] [Related]
20. Multiplex bead analysis of urinary cytokines of type 2 diabetic patients with normo- and microalbuminuria.
Liu J; Zhao Z; Willcox MD; Xu B; Shi B
J Immunoassay Immunochem; 2010; 31(4):279-89. PubMed ID: 21113841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
